ENvue Medical, Inc. (FEED) has taken a significant step toward broadening access to its over-the-counter reusable ENFit Syringes through a newly signed U.S. distribution agreement with U-Deliver, leveraging the partner's digital and wholesale channels to reach non-acute care settings nationwide.
ENvue specializes in intelligent, non-invasive enteral care technologies designed for both clinical and home environments. The company's leadership emphasized that the partnership strengthens its position in the non-acute enteral care market by expanding availability of its recently launched ENFit syringe line, which supports safe feeding and medication delivery for patients and caregivers outside the hospital.
U-Deliver, a U.S.-based supplier focused on home and long-term care, noted that the collaboration aligns with its mission to simplify tube-feeding needs through accessible, affordable products. The company will distribute ENvue's ENFit syringes through its website, Amazon storefront, and wholesale channels.
The reusable ENFit syringes- available in 2.5 mL, 5 mL, 10 mL, and 60 mL sizes- meet ISO 80369-3 global standards and can be reused for up to seven days or 20 uses. They are offered without a prescription, supporting continuity of care across home and long-term care environments.
The stock recently underwent a 1-for-10 reverse stock-split on December 8, 2025.
FEED is currently trading at $2.47, up 135.67%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.